Psychemedics Corporation (PMD)

2.5500 -0.0700 (-2.67%) Al cierre: 04:00PM EDT

Psychemedics Corporation

5220 Spring Valley Road
Suite 230
Dallas, TX 75254
United States
800 527 7424
https://www.psychemedics.com

Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo: 116

Ejecutivos clave

Nombre	Título	Pagar	Ejecutado	Año de nacimiento
Mr. Brian Hullinger	President, CEO & Director	361.37k	N/D	1968
Ms. Daniella Mehalik	Vice President of Finance	126.41k	N/D	1990
Ms. Shannon Shoemaker	Chief Revenue Officer	187.82k	N/D	N/D
Dr. Werner A. Baumgartner Ph.D.	Founder	N/D	N/D	N/D
Ms. Annette Baumgartner	Founder	N/D	N/D	N/D
Mr. Michael Weisenhoff	Principal Financial & Accounting Manager	N/D	N/D	1990
Mr. Patrick J. Kinney Jr.	Secretary	N/D	N/D	N/D

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

Gestión corporativa

La calificación ISS Governance QuickScore de Psychemedics Corporation a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.